Jarratt Pytell, MD
Assistant Professor, Medicine-Internal Medicine

Photo
Medical School:
  • MD, Louisiana State University School of Medicine in New Orleans (2015)
Graduate School :
  • MHS, Johns Hopkins University Bloomberg School of Public Health (2020)
Undergraduate School:
  • BA, University of Colorado - Boulder (CO) (2008)
Residency:
  • Johns Hopkins University/Bayview Medical Center Program, Internal Medicine (2018)
Fellowships:
  • Johns Hopkins University School of Medicine Program, Addiction Medicine (2019)
Department: Medicine-Internal Medicine

Professional Titles

  • Clinician-Investigator

Research Interests

My research is focused on how to improve the care of people who use alcohol and other drugs in primary care and other general medical settings. This includes conducting research on evidence-based drug testing, understanding the impact of alcohol and other drug use among people with HIV, and a recent focus on implementing patient-reported outcome measures in office-based addiction treatment.

Publications

  • Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder. J Gen Intern Med. 2022 Feb;37(3):593-600. PubMed PMID: 34027611
  • Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Subst Abus. 2022;43(1):633-639. PubMed PMID: 34666636
  • Pytell JD, Thakrar AP, Chander G, Colantuoni E. Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis. J Addict Med. 2022 Jun 25. [Epub ahead of print] PubMed PMID: 35749776
  • Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, Baum MK, Gorbach PM, Javanbakht M, Kipke M, Kirk GD, Mustanski B, Shoptaw S, Siminski S, Moore RD, Chander G. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Mar 3;:109382. [Epub ahead of print] PubMed PMID: 35331580
  • Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, Fojo AT, Mehta SH, Kipke M, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Chander G. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Feb 12;:109355. [Epub ahead of print] PubMed PMID: 35331581
  • Lesko CR, Keruly JC, Moore RD, Shen NM, Pytell JD, Lau B, Fojo AT, Mehta SH, Kipke M, Baum MK, Shoptaw S, Gorbach PM, Mustanski B, Javanbakht M, Siminski S, Chander G. COVID-19 and the HIV continuum in people living with HIV enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Dec 1;241:109355. PubMed PMID: 35331581
  • Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, Baum MK, Gorbach PM, Javanbakht M, Kipke M, Kirk GD, Mustanski B, Shoptaw S, Siminski S, Moore RD, Chander G. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022 Dec 1;241:109382. PubMed PMID: 35331580
  • Pytell JD, Chander G, Thakrar AP, Ogunwole SM, McGinty EE. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J Gen Intern Med. 2022 Nov 17. [Epub ahead of print] PubMed PMID: 36394698
  • Pytell JD, Thakrar AP, Chander G, Colantuoni E. Changes in Alcohol Consumption by Beverage Type Attributable to the COVID-19 Pandemic for 10 States, March 2020 to November 2020: An Ecological Simulation-based Analysis. J Addict Med. 2022 Nov-Dec 01;16(6):e412-e416. PubMed PMID: 35749776
  • Kroll-Desrosiers A, Gutierrez J, Pytell JD. From the Editor's Desk: Ethics in Reviewing. J Gen Intern Med. 2022 Oct 12. [Epub ahead of print] PubMed PMID: 36223041
  • Pytell JD, Sklar MD, Carrese J, Rastegar DA, Gunn C, Chander G. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder. J Gen Intern Med. 2022 Feb;37(3):593-600. PubMed PMID: 34027611
  • Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Subst Abus. 2022;43(1):633-639. PubMed PMID: 34666636
  • Pytell JD, Li X, Thompson C, Lesko CR, Hutton H, McCaul ME, Hutton H, Batey DS, Cachay E, Mayer KH, Napravnik S, Christopoulos K, Yang C, Crane HM, Chander G, & Lau B. The temporal relationship of alcohol use and subsequent self-reported health status among people with HIV. American Journal of Medicine Open. Published online June 2022:100020. DOI: doi:10.1016/j.ajmo.2022.100020
  • Pytell JD, Rastegar DA. Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic. J Subst Abuse Treat. 2021 Jan;120:108155. PubMed PMID: 33298297
  • Pytell JD, Sharfstein JM, Olsen Y. Facilitating Methadone Use in Hospitals and Skilled Nursing Facilities. JAMA Intern Med. 2020 Jan 1;180(1):7-8. PubMed PMID: 31738376
  • Pytell JD, Sharfstein JM, Olsen Y. Additional Barriers to Methadone Use in Hospitals and Skilled Nursing Facilities-Reply. JAMA Intern Med. 2020 Apr 1;180(4):615. PubMed PMID: 32250404
  • Callan J, Pytell J, Ross J, Rastegar DA. Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study. J Addict Med. 2020 Sep Oct;14(5):e274-e276. PubMed PMID: 31977358
  • Pytell JD, Buresh ME, Graddy R. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice. Addict Sci Clin Pract. 2019 Dec 19;14(1):46. PubMed PMID: 31856915
  • Pytell JD, Rastegar DA. Who Leaves Early? Factors Associated With Against Medical Advice Discharge During Alcohol Withdrawal Treatment. J Addict Med. 2018 Nov Dec;12(6):447-452. PubMed PMID: 29939873
View All (19 Total) View Less

Professional Memberships

  • American Society of Addiction Medicine, Member
  • Society of General Internal Medicine, Member

Practice Locations

UCHealth Internal Medicine - Anschutz Medical Campus
1635 Aurora Ct
5th Floor
Aurora, CO 80045
720-848-2300

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation
  • Denver Health Medical Center
  • University of Colorado Hospital
Clinical Interests
I am a general internist and addiction medicine specialist. I specialize in caring for people who use alcohol and other drugs to address substance use and co-occurring medical conditions.

Care Philosophy
Medicine is a public trust. I therefore strive to provide evidence-based, patient-centered care to all patients with a focus on caring for people who use alcohol and other drugs.

General Information

Medical Schools:
  • MD, Louisiana State University School of Medicine in New Orleans (2015)
Graduate Schools:
  • MHS, Johns Hopkins University Bloomberg School of Public Health (2020)
Undergraduate Schools:
  • BA, University of Colorado - Boulder (CO) (2008)
Residency Programs:
  • Johns Hopkins University/Bayview Medical Center Program, Internal Medicine (2018)
Fellowships:
  • Johns Hopkins University School of Medicine Program, Addiction Medicine (2019)
Department: Medicine-Internal Medicine
SOM Resources
CU Resources
Contact Us
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;